| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Ethos Technologies Inc.
13G/A
Amendment 2
LIFE · 29765A101
|
1.8% |
11/6/2026
Event 9/30/2026
|
|||
| GV 2019, L.P. | 0% | ||||
| GV 2019 GP, L.P. | 0% | ||||
| GV 2019 GP, L.L.C. | 0% | ||||
| GV 2021, L.P. | 1.8% | ||||
| GV 2021 GP, L.P. | 1.8% | ||||
| GV 2021 GP, L.L.C. | 1.8% | ||||
| Alphabet Holdings LLC | 1.8% | ||||
| XXVI Holdings Inc. | 1.8% | ||||
| Alphabet Inc. | 1.8% | ||||
|
Ethos Technologies Inc.
13G/A
Amendment 1
LIFE · 29765A101
|
11.7% |
8/7/2026
Event 6/30/2026
|
|||
| GV 2019, L.P. | 9.9% | ||||
| GV 2019 GP, L.P. | 9.9% | ||||
| GV 2019 GP, L.L.C. | 9.9% | ||||
| GV 2021, L.P. | 1.8% | ||||
| GV 2021 GP, L.P. | 1.8% | ||||
| GV 2021 GP, L.L.C. | 1.8% | ||||
| Alphabet Holdings LLC | 11.7% | ||||
| XXVI Holdings Inc. | 11.7% | ||||
| Alphabet Inc. | 11.7% | ||||
|
Ethos Technologies Inc.
13G
LIFE · 29765A101
|
12.2% |
5/1/2026
Event 3/31/2026
|
|||
| GV 2019, L.P. | 10.4% | ||||
| GV 2019 GP, L.P. | 10.4% | ||||
| GV 2019 GP, L.L.C. | 10.4% | ||||
| GV 2021, L.P. | 1.9% | ||||
| GV 2021 GP, L.P. | 1.9% | ||||
| GV 2021 GP, L.L.C. | 1.9% | ||||
| Alphabet Holdings LLC | 12.2% | ||||
| XXVI Holdings Inc. | 12.2% | ||||
| Alphabet Inc. | 12.2% | ||||
|
Maze Therapeutics, Inc.
13G/A
Amendment 1
MAZE · 578784100
|
2.9% |
2/6/2026
Event 12/31/2025
|
|||
| GV 2019, L.P. | 1.6% | ||||
| GV 2019 GP, L.P. | 1.6% | ||||
| GV 2019 GP, L.L.C. | 1.6% | ||||
| GV 2023, L.P. | 1.3% | ||||
| GV 2023 GP, L.P. | 1.3% | ||||
| GV 2023 GP, L.L.C. | 1.3% | ||||
| Alphabet Holdings LLC | 2.9% | ||||
| XXVI Holdings Inc. | 2.9% | ||||
| Alphabet Inc. | 2.9% | ||||
|
Prime Medicine, Inc.
13G/A
Amendment 3
PRME · 74168J101
|
12.3% |
11/12/2025
Event 9/30/2025
|
|||
| GV 2019, L.P. | 7.5% | ||||
| GV 2019 GP, L.P. | 7.5% | ||||
| GV 2019 GP, L.L.C. | 7.5% | ||||
| GV 2021, L.P. | 2.4% | ||||
| GV 2021 GP, L.P. | 2.4% | ||||
| GV 2021 GP, L.L.C. | 2.4% | ||||
| GV 2023, L.P. | 2.4% | ||||
| GV 2023 GP, L.P. | 2.4% | ||||
| GV 2023 GP, L.L.C. | 2.4% | ||||
| Alphabet Holdings LLC | 12.3% | ||||
| XXVI Holdings Inc. | 12.3% | ||||
| Alphabet Inc. | 12.3% | ||||
|
Maze Therapeutics, Inc.
13G
MAZE · 578784100
|
5.5% |
5/9/2025
Event 3/31/2025
|
|||
| GV 2019, L.P. | 4.1% | ||||
| GV 2019 GP, L.P. | 4.1% | ||||
| GV 2019 GP, L.L.C. | 4.1% | ||||
| GV 2023, L.P. | 1.4% | ||||
| GV 2023 GP, L.P. | 1.4% | ||||
| GV 2023 GP, L.L.C. | 1.4% | ||||
| Alphabet Holdings LLC | 5.5% | ||||
| XXVI Holdings Inc. | 5.5% | ||||
| Alphabet Inc. | 5.5% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.